Lithium Ion

Lithium Ion

SCHEMBL193640

O=S(=O)([O-])/C=C/c1ccccc1.[Li+]

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PPARG P37231 7/20 0.52
LMNA P02545 3/20 0.52
NFE2L2 Q16236 2/20 0.52
PKM P14618 1/20 0.44
KMT2A Q03164 1/20 0.44
MAOB P27338 1/20 0.44
FBP1 P09467 1/20 0.43
HSP90AA1 P07900 2/20 0.43
MAPK1 P28482 2/20 0.43
TSHR P16473 1/20 0.43
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ALDH1A1 P00352 2/20 0.43
TRPA1 O75762 1/20 0.43
ALOX5 P09917 1/20 0.43
PTGES2 Q9H7Z7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL4342322 1.00 PPARG (0.52) PPARGLMNANFE2L2PKMKMT2A
Lithium Ion SCHEMBL193641 1.00 PPARG (0.52) PPARGLMNANFE2L2PKMKMT2A
SCHEMBL11600944 0.95 PPARG (0.52) PPARGLMNANFE2L2PKMKMT2A
SCHEMBL4339905 0.95 PPARG (0.52) PPARGLMNANFE2L2PKMKMT2A
SCHEMBL6436967 0.95 PPARG (0.52) PPARGLMNANFE2L2PKMKMT2A
SCHEMBL6439767 0.95 PPARG (0.52) PPARGLMNANFE2L2PKMKMT2A
SCHEMBL3002303 0.95 PPARG (0.52) PPARGLMNANFE2L2PKMKMT2A
SCHEMBL2138985 0.95 PPARG (0.52) PPARGLMNANFE2L2PKMKMT2A
SCHEMBL1565614 0.95 PPARG (0.52) PPARGLMNANFE2L2PKMKMT2A
SCHEMBL2997852 0.95 PPARG (0.52) PPARGLMNANFE2L2PKMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3031798-B1 A novel cross-linker for the preparation of a new family of single ion conduction polymers for electrochemical devices and such polymers BELENOS CLEAN POWER HOLDING AG (CH) 2017-09-27 EP disclosed
US-9771319-B2 Cross-linker for the preparation of a new family of single ion conduction polymers for electrochemical devices and such polymers BELENOS CLEAN POWER HOLDING AG (CH) 2017-09-26 US disclosed
US-20160168086-A1 NOVEL CROSS-LINKER FOR THE PREPARATION OF A NEW FAMILY OF SINGLE ION CONDUCTION POLYMERS FOR ELECTROCHEMICAL DEVICES AND SUCH POLYMERS BELENOS CLEAN POWER HOLDING AG (CH) 2016-06-16 US disclosed
EP-3031798-A1 A novel cross-linker for the preparation of a new family of single ion conduction polymers for electrochemical devices and such polymers Belenos Clean Power Holding AG (CH) 2016-06-15 EP disclosed
US-8786932-B2 Advanced electrode structures and electrochromic devices NTERA, INC. (US) 2014-07-22 US disclosed
US-8511841-B2 Vehicular blind spot indicator mirror DONNELLY CORPORATION (US) 2013-08-20 US disclosed
US-20120038967-A1 ADVANCED ELECTRODE STRUCTURES AND ELECTROCHROMIC DEVICES NTERA LIMITED (IE) 2012-02-16 US disclosed
EP-2401650-A1 ADVANCED ELECTRODE STRUCTURES AND ELECTROCHROMIC DEVICES Ntera, Inc. (US) 2012-01-04 EP disclosed
US-20110128137-A1 VEHICULAR BLIND SPOT INDICATOR MIRROR DONNELLY CORPORATION (US) 2011-06-02 US disclosed
US-7871169-B2 Vehicular signal mirror DONNELLY CORPORATION (US) 2011-01-18 US disclosed
EP-1224505-A1 ELECTROCHROMIC DEVICE UNIVERSITY COLLEGE DUBLIN (IE) 2002-07-24 EP disclosed
US-20020041443-A1 Electrochromic mirrors and devices VARAPRASAD DESARAJU V (US) 2002-04-11 US disclosed
EP-0758929-B1 ELECTROCHROMIC MIRRORS AND DEVICES DONNELLY CORP (US) 2002-01-09 EP disclosed
EP-1152285-A2 Electrochromic mirrors and devices DONNELLY CORPORATION (US) 2001-11-07 EP disclosed
WO-2001027690-A2 ELECTROCHROMIC DEVICE UNIVERSITY COLLEGE DUBLIN (IE) 2001-04-19 WO disclosed
US-5724187-A FOR A MOTOR VEHICLE DONNELLY CORPORATION (US) 1998-03-03 US disclosed
US-5668663-A ELEMENT COMPOSED OF A SOLID FILM AND AN ELECTROLYTE COMPRISING REDOX REACTION PROMOTERS AND ALKALI IONS AND/OR PROTONS DONNELLY CORPORATION (US) 1997-09-16 US disclosed
EP-0758929-A4 ELECTROCHROMIC MIRRORS AND DEVICES DONNELLY CORP (US) 1997-08-06 EP disclosed
EP-0758929-A1 ELECTROCHROMIC MIRRORS AND DEVICES DONNELLY CORPORATION (US) 1997-02-26 EP disclosed
WO-1995030495-A1 ELECTROCHROMIC MIRRORS AND DEVICES DONNELLY CORPORATION (US) 1995-11-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160168086-A1 NOVEL CROSS-LINKER FOR THE PREPARATION OF A NEW FAMILY OF SINGLE ION CONDUCTION POLYMERS FOR ELECTROCHEMICAL DEVICES AND SUCH POLYMERS PPOX, PFAS, LPO PPARG 1478/4885LMNA 1965/4885NFE2L2 1243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.